Physiopathogenesis of Hematological Cancer

Indexed in: Scopus, EBSCO.

The number of new discoveries related to diagnostics and therapeutics of hematological cancer is significant. These have resulted in continuous progress in fundamental knowledge about molecular and ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

Physiopathogenesis of Lymphoma

Pp. 151-167 (17)

Edgar Gil Rizzatti


The term lymphoma encompasses both Hodgkin and non-Hodgkin lymphoma and comprises several lymphoproliferative malignant diseases with remarkable biological and clinical heterogeneity. Hodgkin lymphoma is recognized by the presence of Reed-Sternberg cells in involved tissues and almost all cases are originated from B-cells. Non-Hodgkin lymphomas are also predominantly derived from B-cells, and only 12% of the cases have a T-cell or NK-cell origin. Non-Hodgkin lymphomas do not present any characteristic cell type and the great majority of the cells in the tumor are clonally derived from a transformed precursor. In this chapter, the biology, cellular origin and molecular pathogenesis of lymphomas are discussed, focusing on the most common subtypes of B-cell non- Hodgkin lymphomas. Selected topics of the epidemiology, clinical presentation and diagnosis of lymphomas are also introduced, and an overview of the main issues related to pretreatment evaluation, staging and treatment of lymphomas is provided.


Lymphoid tissues, B-cell lymphomas, immunoglobulin genes, Mantle cell lymphoma, 9p21 deletion, Indolent lymphomas, Aggressive lymphomas, Diagnosis of Hodgkin lymphoma, Staging and Pretreatment of Lymphomas, Evaluation of Lymphomas, Treatment and Prognosis of Lymphomas.


Fleury Group, Avenida General Valdomiro de Lima, 508.04344-903 Sao Paulo, SP Brazil.